Broadside Enterprises Inc. (BRSE)

[equijohn]

BROADSIDE ENTERPRISES, INC.
Stock Symbol BRSE

I am optimistic about BRSE for many different factors
• Share Structure is amazing for an OTC company and the Outstanding Shares “under 10 million shares “and Float “Under 5 million shares “have remained unchanged in 5 years, unheard in the OTC world.
https://www.otcmarkets.com/stock/BRSE/security
The company increased the Authorized shares to be used in reverse merger when the CEO Christopher Petzel finds the right opportunity. The shares used in a Reverse Merger would be restricted, so as not to dilute the current shareholders. Even at 199 million AS, that is amongst the best on the OTC Markets.
On October 16, 2020, the Company increased its authorized share capital to 200,000,000 shares composed of 199,000,000 shares of Common Stock and 1,000,000 shares of Preferred Stock in anticipation of a potential reverse merger transaction. From the most recent Filing
• The CEO has kept the company current as it regards to quarterly and annual filings
https://www.otcmarkets.com/stock/BRSE/disclosure
• Very Low convertible debt, and held by large stake shareholders, the largest convertible note has an exercise price of .50 which is 10X what the stock is trading at now.
From most recent filing
• Past Press Releases from BRSE have resulted in substantial increases in price per share. in 2021 the Stock saw increases to .485 and .51. in September of 2021 Christopher Petzel Canceled the Monte Cristo International deal which subsequently reset the share structure and allow Mr. Petzel to find a better reverse merger partner for BRSE.
• Christopher Petzel Holds BRSE Options for which he could have executed during the previous increases in the Price per share, this would have made Mr. Petzel huge increases, and he did not exercise those options, and my belief is he is waiting for larger gains, which I believe with Mr. Petzels experience and connections is more than possible.
In 2016, the Company issued an option to the Company’s Chief Executive Officer, Christopher Petzel, to purchase 2,000,000 (split adjusted) shares at an exercise price of 0.10 per share with an expiration date of December 31, 2026 From Most Recent Filing
• Strong inside ownership and none of them have sold in the past 5 years
From most recent filing
James Zukin- Zukin Capital – 5% shareholder
https://zukinpartners.com/jim-zukin/
• What makes me optimistic about this company and the opportunity is CEO Christopher Petzel.
1. Has Extensive Experience in the Entertainment industry
https://www.imdb.com/name/nm0678850/
2. Has Experience in Finance and venture capital
https://www.dt2invest.com/lecturers-panellists/christopher-petzel
3. Sits on the Board of Directors of a NYSE company, AREN, which he was part of the team that helped them move from the OTC Markets to the New York Stock Exchange
https://thearenagroup.net/christopher-petzel/
4. Is the Chairman of the Board of Byte To Bite Industries
https://disclosurequest.com/form/byte-to-bite-industries-inc./0001898701-22-000001
https://bytetobite.industries/
• Finally, I will just say that based on Share Structure, inside ownership, convertible debt, and past performance, BRSE is my Top OTC pick. No pump groups associated with it, no dilution, no bad actors.